ApoE and pulse pressure interactively influence level and change in the aging of episodic memory: Protective effects among ε2 carriers

Neuropsychology

Volumn 29, Issue 3, 2015, Pages 388-401

  Peggy McFall, G ^a   Wiebe, Sandra A ^a   Vergote, David ^b   Westaway, David ^b   Jhamandas, Jack ^a   Bäckman, Lars ^c   Dixon, Roger A ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Aging; Apolipoprotein E; Episodic memory; Pulse pressure; Victoria Longitudinal Study

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E2;

ADULT; AGED; AGING; ALLELE; ARTICLE; DECLARATIVE MEMORY; EPISODIC MEMORY; FACT RECALL; FEMALE; GENOTYPE; HUMAN; LEARNING; LONGITUDINAL STUDY; MALE; MENTAL HEALTH; PRIORITY JOURNAL; PROCESS MODEL; PULSE PRESSURE; REY AUDITORY VERBAL LEARNING; RISK FACTOR; SEMANTIC MEMORY; WORD RECOGNITION; BLOOD PRESSURE; GENETICS; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PHYSIOLOGY; PSYCHOLOGICAL MODEL; PSYCHOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AGING; ALLELES; APOLIPOPROTEIN E2; BLOOD PRESSURE; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MEMORY, EPISODIC; MIDDLE AGED; MODELS, PSYCHOLOGICAL; NEUROPSYCHOLOGICAL TESTS; RISK FACTORS;

EID: 84928987965     PISSN: 08944105     EISSN: 19311559     Source Type: Journal    
DOI: 10.1037/neu0000150     Document Type: Article

References (103)

1. Anstey, K. J. (2012). Biomarkers and memory aging: A life-course perspective. In M. Naveh-Benjamin & N. Ohta (Eds.), Memory and aging (pp. 349-372). New York, NY: Psychology Press.
2. Anstey, K., & Christensen, H. (2000). Education, activity, health, blood pressure and apolipoprotein E as predictors of cognitive change in old age: A review. Gerontology, 46, 163-177. http://dx.doi.org/10.1159/000022153
3. Bell, R. D., Winkler, E. A., Singh, I., Sagare, A. P., Deane, R., Wu, Z., . . . Zlokovic, B. V. (2012). Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Nature, 485, 512-516.
4. Bender, A. R., & Raz, N. (2012). Age-related differences in episodic memory: A synergistic contribution of genetic and physiological vascular risk factors. Neuropsychology, 26, 442-450. http://dx.doi.org/10.1037/a0028669
5. Bennet, A. M., Di Angelantonio, E., Ye, Z., Wensley, F., Dahlin, A., Ahlbom, A., . . . Danesh, J. (2007). Association of apolipoprotein E genotypes with lipid levels and coronary risk. Journal of the American Medical Association, 298, 1300-1311. http://dx.doi.org/10.1001/jama.298.11.1300
6. Berlau, D. J., Corrada, M. M., Head, E., & Kawas, C. H. (2009). APOE ε2 is associated with intact cognition but increased Alzheimer pathology in the oldest old. Neurology, 72, 829-834. http://dx.doi.org/10.1212/01.wnl.0000343853.00346.a4
7. Bertram, L., McQueen, M. B., Mullin, K., Blacker, D., & Tanzi, R. E. (2007). Systematic meta-analyses of Alzheimer disease genetic association studies: The AlzGene database. Nature Genetics, 39, 17-23. http://dx.doi.org/10.1038/ng1934
8. Brainerd, C. J., Reyna, V. F., Petersen, R. C., Smith, G. E., & Taub, E. S. (2011). Is the apolipoprotein e genotype a biomarker for mild cognitive impairment? Findings from a nationally representative study. Neuropsychology, 25, 679-689. http://dx.doi.org/10.1037/a0024483
9. Buckner, R. L. (2004). Memory and executive function in aging and AD: Multiple factors that cause decline and reserve factors that compensate. Neuron, 44, 195-208. http://dx.doi.org/10.1016/j.neuron.2004.09.006
10. Bunce, D., Anstey, K. J., Burns, R., Christensen, H., & Easteal, S. (2011). Does possession of apolipoprotein E ε4 benefit cognitive function in healthy young adults? Neuropsychologia, 49, 1693-1697. http://dx.doi.org/10.1016/j.neuropsychologia.2011.02.042
11. Caselli, R. J., Dueck, A. C., Locke, D. E. C., Sabbagh, M. N., Ahern, G. L., Rapcsak, S. Z., . . . Reiman, E. M. (2011). Cerebrovascular risk factors and preclinical memory decline in healthy APOE ε4 homozygotes. Neurology, 76, 1078-1084. http://dx.doi.org/10.1212/WNL.0b013e318211c3ae
12. Cattin, L., Fisicaro, M., Tonizzo, M., Valenti, M., Danek, G. M., Fonda, M., . . . Baralle, F. (1997). Polymorphism of the apolipoprotein E gene and early carotid atherosclerosis defined by ultrasonography in asymptomatic adults. Arteriosclerosis, Thrombosis, and Vascular Biology, 17, 91-94. http://dx.doi.org/10.1161/01.ATV.17.1.91
13. Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., . . . Pericak-Vance, M. A. (1993). Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science, 261, 921-923. http://dx.doi.org/10.1126/science.8346443
14. Dahle, C. L., Jacobs, B. S., & Raz, N. (2009). Aging, vascular risk, and cognition: Blood glucose, pulse pressure, and cognitive performance in healthy adults. Psychology and Aging, 24, 154-162. http://dx.doi.org/10.1037/a0014283
15. Dart, A. M., & Kingwell, B. A. (2001). Pulse pressure: A review of mechanisms and clinical relevance. Journal of the American College of Cardiology, 37, 975-984. http://dx.doi.org/10.1016/S0735-1097(01)01108-1
16. Davenport, M. H., Hogan, D. B., Eskes, G. A., Longman, R. S., & Poulin, M. J. (2012). Cerebrovascular reserve: The link between fitness and cognitive function? Exercise and Sport Sciences Reviews, 40, 153-158.
17. Deane, R., Sagare, A., Hamm, K., Parisi, M., Lane, S., Finn, M. B., . . . Zlokovic, B. V. (2008). apoE isoform-specific disruption of amyloid βpeptide clearance from mouse brain. The Journal of Clinical Investigation, 118, 4002-4013. http://dx.doi.org/10.1172/JCI36663
18. Deary, I. J., Whiteman, M. C., Pattie, A., Starr, J. M., Hayward, C., Wright, A. F., . . . Whalley, L. J. (2004). Apolipoprotein e gene variability and cognitive functions at age 79: A follow-up of the Scottish mental survey of 1932. Psychology and Aging, 19, 367-371. http://dx.doi.org/10.1037/0882-7974.19.2.367
19. Dixon, R. A., DeCarlo, C. A., MacDonald, S. W., Vergote, D., Jhamandas, J., & Westaway, D. (2014). APOE and COMT polymorphisms are complementary biomarkers of status, stability, and transitions in normal aging and early mild cognitive impairment. Frontiers in Aging Neuroscience, 6, 236. http://dx.doi.org/10.3389/fnagi.2014.00236
20. Dixon, R. A., & de Frias, C. M. (2004). The Victoria Longitudinal Study: From characterizing cognitive aging to illustrating changes in memory compensation. Aging, Neuropsychology, and Cognition, 11, 346-376. http://dx.doi.org/10.1080/13825580490511161
21. Dixon, R. A., Small, B. J., MacDonald, S. W. S., & McArdle, J. J. (2012). Yes, memory declines with aging: But when, how, and why? In M. Naveh-Benjamin & N. Ohta (Eds.), Memory and aging (pp. 325-348). New York, NY: Psychology Press.
22. Dixon, R. A., Wahlin, Å., Maitland, S. B., Hultsch, D. F., Hertzog, C., & Bäckman, L. (2004). Episodic memory change in late adulthood: Generalizability across samples and performance indices. Memory & Cognition, 32, 768-778. http://dx.doi.org/10.3758/BF03195867
23. Dolcos, S., MacDonald, S. W. S., Braslavsky, A., Camicioli, R., & Dixon, R. A. (2012). Mild cognitive impairment is associated with selected functional markers: Integrating concurrent, longitudinal, and stability effects. Neuropsychology, 26, 209-223. http://dx.doi.org/10.1037/a0026760
24. Ekstrom, R. B., French, J. W., Harman, H., & Derman, D. (1976). Kit of factor-referenced cognitive tests (rev. ed.). Princeton, NJ: Educational Testing Service.
25. Elias, M. F., Elias, P. K., Sullivan, L. M., Wolf, P. A., & D'Agostino, R. B. (2003). Lower cognitive function in the presence of obesity and hypertension: The Framingham heart study. International Journal of Obesity, 27, 260-268. http://dx.doi.org/10.1038/sj.ijo.802225
26. Elias, P. K., Elias, M. F., Robbins, M. A., & Budge, M. M. (2004). Blood pressure-related cognitive decline: Does age make a difference? Hypertension, 44, 631-636. http://dx.doi.org/10.1161/01.HYP.0000145858.07252.99
27. Enders, C. K. (2011). Analyzing longitudinal data with missing values. Rehabilitation Psychology, 56, 267-288. http://dx.doi.org/10.1037/a0025579
28. Ferencz, B., Laukka, E. J., Lövdén, M., Kalpouzos, G., Keller, L., Graff, C., . . . Bäckman, L. (2013). The influence of APOE and TOMM40 polymorphisms on hippocampal volume and episodic memory in old age. Frontiers in Human Neuroscience, 7, 198. http://dx.doi.org/10.3389/fnhum.2013.00198
29. Ferencz, B., Laukka, E. J., Welmer, A.-K., Kalpouzos, G., Angleman, S., Keller, L., . . . Bäckman, L. (2014). The benefits of staying active in old age: Physical activity counteracts the negative influence of PICALM, BIN1, and CLU risk alleles on episodic memory functioning. Psychology and Aging, 29, 440-449. http://dx.doi.org/10.1037/a0035465
30. Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189-198. http://dx.doi.org/10.1016/0022-3956(75)90026-6
31. Fotuhi, M., Hachinski, V., & Whitehouse, P. J. (2009). Changing perspectives regarding late-life dementia. Nature Reviews Nephrology, 5, 649-658. http://dx.doi.org/10.1038/nrneurol.2009.175
32. Franklin, S. S., Gustin, W., IV, Wong, N. D., Larson, M. G., Weber, M. A., Kannel, W. B., & Levy, D. (1997). Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation, 96, 308-315. http://dx.doi.org/10.1161/01.CIR.96.1.308
33. Gomar, J. J., Bobes-Bascaran, M. T., Conejero-Goldberg, C., Davies, P., Goldberg, T. E., & the Alzheimer's Disease Neuroimaging Initiative. (2011). Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer's disease neuroimaging initiative. Archives of General Psychiatry, 68, 961-969. http://dx.doi.org/10.1001/archgenpsychiatry.2011.96
34. Graham, J. W., Olchowski, A. E., & Gilreath, T. D. (2007). How many imputations are really needed? Some practical clarifications of multiple imputation theory. Prevention Science, 8, 206-213. http://dx.doi.org/10.1007/s11121-007-0070-9
35. Harris, S. E., & Deary, I. J. (2011). The genetics of cognitive ability and cognitive ageing in healthy older people. Trends in Cognitive Sciences, 15, 388-394.
36. Hatters, D. M., Peters-Libeu, C. A., & Weisgraber, K. H. (2006). Apolipoprotein E structure: Insights into function. Trends in Biochemical Sciences, 31, 445-454. http://dx.doi.org/10.1016/j.tibs.2006.06.008
37. Hertzog, C. (2008). Theoretical approaches to the study of cognitive aging: An individual-differences perspective. In S. M. Hofer & D. F. Alwin (Eds.), Handbook of cognitive aging: Interdisciplinary perspectives (pp.34-49). Thousand Oaks, CA: Sage. http://dx.doi.org/10.4135/9781412976589.n2
38. Jochemsen, H. M., Muller, M., van der Graaf, Y., & Geerlings, M. I. (2012). APOE ε4 differentially influences change in memory performance depending on age. The SMART-MR study. Neurobiology of Aging, 33, 832.e15-832.e22. http://dx.doi.org/10.1016/j.neurobiolaging.2011.07.016
39. Josefsson, M., de Luna, X., Pudas, S., Nilsson, L.-G., & Nyberg, L. (2012). Genetic and lifestyle predictors of 15-year longitudinal change in episodic memory. Journal of the American Geriatrics Society, 60, 2308-2312. http://dx.doi.org/10.1111/jgs.12000
40. Kalpouzos, G., & Nyberg, L. (2012). Multimodal neuroimaging in normal aging: Structure-function interactions. In M. Naveh-Benjamin & N. Ohta (Eds.), Memory and aging (pp. 273-304). New York, NY: Psychology Press.
41. Kivipelto, M., Rovio, S., Ngandu, T., Kåreholt, I., Eskelinen, M., Winblad, B., . . . Nissinen, A. (2008). Apolipoprotein E ε4 magnifies lifestyle risks for dementia: A population-based study. Journal of Cellular and Molecular Medicine, 12, 2762-2771. http://dx.doi.org/10.1111/j.1582-4934.2008.00296.x
42. Kline, R. B. (2011). Principles and practice of structural equation modeling (3rd ed.). New York, NY: Guilford Press.
43. Laukka, E. J., Lövdén, M., Herlitz, A., Karlsson, S., Ferencz, B., Pantzar, A., . . . Bäckman, L. (2013). Genetic effects on old-age cognitive functioning: A population-based study. Psychology and Aging, 28, 262-274. http://dx.doi.org/10.1037/a0030829
44. Lee, B. K., Glass, T. A., Wand, G. S., McAtee, M. J., Bandeen-Roche, K., Bolla, K. I., & Schwartz, B. S. (2008). Apolipoprotein e genotype, cortisol, and cognitive function in community-dwelling older adults. The American Journal of Psychiatry, 165, 1456-1464. http://dx.doi.org/10.1176/appi.ajp.2008.07091532
45. Lezak, M. D. (1983). Neuropsychological assessment. New York, NY: Oxford University Press.
46. Lind, J., & Nyberg, L. (2010). Imaging genomics: Brain alterations associated withAPOE genotype. In L. Bäckman & L. Nyberg (Eds.), Memory, aging and the brain: A festschrift in honour of Lars-Göran Nilsson (pp. 300-328). New York, NY: Psychology Press.
47. Lindahl-Jacobsen, R., Tan, Q., Mengel-From, J., Christensen, K., Nebel, A., & Christiansen, L. (2012). Effects of the ApoE ε2 allele on mortality and cognitive function in the oldest old. Journals of Gerontology: A Biological Sciences and Medical Sciences, 68, 389-394.
48. Lindenberger, U., Nagel, I. E., Chicherio, C., Li, S.-C., Heekeren, H. R., & Bäckman, L. (2008). Age-related decline in brain resources modulates genetic effects on cognitive functioning. Frontiers in Neuroscience, 2, 234-244. http://dx.doi.org/10.3389/neuro.01.039.2008
49. Little, T. D. (2013). Longitudinal structural equation modeling. New York, NY: Guilford Press.
50. Luck, T., Riedel-Heller, S. G., Luppa, M., Wiese, B., Köhler, M., Jessen, F., . . . Maier, W. (2013). Apolipoprotein E epsilon 4 genotype and a physically active lifestyle in late life: Analysis of gene-environment interaction for the risk of dementia and Alzheimer's disease dementia. [Advance online publication]. Psychological Medicine, 7, 1-11.
51. MacDonald, S. W. S., DeCarlo, C. A., & Dixon, R. A. (2011). Linking biological and cognitive aging: Toward improving characterizations of developmental time. The Journals of Gerontology Series B: Psychological Sciences and Social Sciences, 66(Suppl. 1), i59-i70. http://dx.doi.org/10.1093/geronb/gbr039
52. Mahley, R. W. (1988). Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology. Science, 240, 622-630. http://dx.doi.org/10.1126/science.3283935
53. Mahley, R. W., & Huang, Y. (2012). Apolipoprotein e sets the stage: Response to injury triggers neuropathology. Neuron, 76, 871-885. http://dx.doi.org/10.1016/j.neuron.2012.11.020
54. Mahley, R. W., & Rall, S. C., Jr. (2000). Apolipoprotein E: Far more than a lipid transport protein. Annual Review of Genomics and Human Genetics, 1, 507-537. http://dx.doi.org/10.1146/annurev.genom.1.1.507
55. Mahley, R. W., Weisgraber, K. H., & Huang, Y. (2009). Apolipoprotein E: Structure determines function, from atherosclerosis to Alzheimer's disease to AIDS. Journal of Lipid Research, 50 (Suppl.), S183-S188. http://dx.doi.org/10.1194/jlr.R800069-JLR200
56. Mattace-Raso, F. U., van der Cammen, T. J., Hofman, A., van Popele, N. M., Bos, M. L., Schalekamp, M. A., . . . Witteman, J. C. (2006). Arterial stiffness and risk of coronary heart disease and stroke: The Rotterdam Study. Circulation, 113, 657-663. http://dx.doi.org/10.1161/CIRCULATIONAHA.105.555235
57. McArdle, J. J., & Prescott, C. A. (2010). Contemporary modeling of gene X environment effects in randomized multivariate longitudinal studies. Perspectives on Psychological Science, 5, 606-621. http://dx.doi.org/10.1177/1745691610383510
58. McFall, G. P., Wiebe, S. A., Vergote, D., Jhamandas, J., Westaway, D., & Dixon, R. A. (2014). IDE (rs6583817) polymorphism and pulse pressure are independently and interactively associated with level and change in executive function in older adults. Psychology and Aging, 29, 418-430. http://dx.doi.org/10.1037/a0034656
59. McFall, G. P., Wiebe, S. A., Vergote, D., Westaway, D., Jhamandas, J., & Dixon, R. A. (2013). IDE (rs6583817) polymorphism and type 2 diabetes differentially modify executive function in older adults. Neurobiology of Aging, 34, 2208-2216. http://dx.doi.org/10.1016/j.neurobiolaging.2013.03.010
60. Mitchell, G. F., Vasan, R. S., Keyes, M. J., Parise, H., Wang, T. J., Larson, M. G., . . . Benjamin, E. J. (2007). Pulse pressure and risk of new-onset atrial fibrillation. Journal of the American Medical Association, 297, 709-715. http://dx.doi.org/10.1001/jama.297.7.709
61. Mitnitski, A., Song, X., & Rockwood, K. (2013). Assessing biological aging: The origin of deficit accumulation. Biogerontology, 14, 709-717. http://dx.doi.org/10.1007/s10522-013-9446-3
62. Morra, L., Zade, D., McGlinchey, R. E., & Milberg, W. P. (2013). Normal aging and cognition: The unacknowledged contribution of cerebrovascular risk factors. Aging, Neuropsychology, and Cognition, 20, 271-297. http://dx.doi.org/10.1080/13825585.2012.693905
63. Muthén, L. K., & Muthén, B. O. (2010). Mplus user's guide (6th ed.). Los Angeles, CA: Muthén & Muthén.
64. Nation, D. A., Edland, S. D., Bondi, M. W., Salmon, D. P., Delano-Wood, L., Peskind, E. R., . . . Galasko, D. R. (2013). Pulse pressure is associated with Alzheimer biomarkers in cognitively normal older adults. Neurology, 81, 2024-2027. http://dx.doi.org/10.1212/01.wnl.0000436935.47657.78
65. Nelson, T. O., & Narens, L. (1980). Norms of 300 general-information questions: Accuracy of recall, latency of recall, and feeling-of-knowing ratings. Journal of Verbal Learning and Verbal Behavior, 19, 338-368. http://dx.doi.org/10.1016/S0022-5371(80)90266-2
66. Nilsson, L.-G., Adolfsson, R., Bäckman, L., Cruts, M., Nyberg, L., Small, B. J., & Van Broeckoven, C. (2006). The influence of APOE status on episodic and semantic memory: Data from a population-based study. Neuropsychology, 20, 645-657. http://dx.doi.org/10.1037/0894-4105.20.6.645
67. Nilsson, L.-G., Bäckman, L., Erngrund, K., Nyberg, L., Adolfsson, R., Bucht, G. Ö. S., Winblad, B. . . . (1997). The Betula prospective cohort study: Memory, health, and aging. Aging, Neuropsychology, and Cognition, 4 1-32. http://dx.doi.org/10.1080/13825589708256633
68. Nyberg, L., Lövdén, M., Riklund, K., Lindenberger, U., & Bäckman, L. (2012). Memory aging and brain maintenance. Trends in Cognitive Sciences, 16, 292-305. http://dx.doi.org/10.1016/j.tics.2012.04.005
69. Nyberg, L., Maitland, S. B., Rönnlund, M., Bäckman, L., Dixon, R. A., Wahlin, Å., & Nilsson, L. G. (2003). Selective adult age differences in an age-invariant multifactor model of declarative memory. Psychology and Aging, 18, 149-160. http://dx.doi.org/10.1037/0882-7974.18.1.149
70. Pase, M. P., Pipingas, A., Kras, M., Nolidin, K., Gibbs, A. L., Wesnes, K. A., . . . Stough, C. (2010). Healthy middle-aged individuals are vulnerable to cognitive deficits as a result of increased arterial stiffness. Journal of Hypertension, 28, 1724-1729. http://dx.doi.org/10.1097/HJH.0b013e32833b1ee7
71. Plassman, B. L., Williams, J. W., Jr., Burke, J. R., Holsinger, T., & Benjamin, S. (2010). Systematic review: Factors associated with risk for and possible prevention of cognitive decline in later life. Annals of Internal Medicine, 153, 182-193. http://dx.doi.org/10.7326/0003-4819-153-3-201008030-00258
72. Qiu, C., Winblad, B., Viitanen, M., & Fratiglioni, L. (2003). Pulse pressure and risk of Alzheimer disease in persons aged 75 years and older: A community-based, longitudinal study. Stroke, 34, 594-599. http://dx.doi.org/10.1161/01.STR.0000060127.96986.F4
73. Raz, N., Dahle, C. L., Rodrigue, K. M., Kennedy, K. M., & Land, S. (2011). Effects of age, genes, and pulse pressure on executive functions in healthy adults. Neurobiology of Aging, 32, 1124-1137. http://dx.doi.org/10.1016/j.neurobiolaging.2009.05.015
74. Raz, N., Lindenberger, U., Rodrigue, K. M., Kennedy, K. M., Head, D., Williamson, A., . . . Acker, J. D. (2005). Regional brain changes in aging healthy adults: General trends, individual differences and modifiers. Cerebral Cortex, 15, 1676-1689. http://dx.doi.org/10.1093/cercor/bhi044
75. Raz, N., Rodrigue, K. M., Kennedy, K. M., & Land, S. (2009). Genetic and vascular modifiers of age-sensitive cognitive skills: Effects of COMT, BDNF, ApoE, and hypertension. Neuropsychology, 23, 105-116. http://dx.doi.org/10.1037/a0013487
76. Reynolds, C. A., Gatz, M., Berg, S., & Pedersen, N. L. (2007). Genotypeenvironment interactions: Cognitive aging and social factors. Twin Research and Human Genetics, 10, 241-254. http://dx.doi.org/10.1375/twin.10.2.241
77. Rodrigue, K. M., Rieck, J. R., Kennedy, K. M., Devous, M. D., Sr., Diaz-Arrastia, R., & Park, D. C. (2013). Risk factors for β-amyloid deposition in healthy aging: Vascular and genetic effects. Journal of the American Medical Association Neurology, 70, 600-606. http://dx.doi.org/10.1001/jamaneurol.2013.1342
78. Rubin, D. B. (1987). Multiple imputations for nonresponse in surveys. Hoboken, NJ: Wiley. http://dx.doi.org/10.1002/9780470316696
79. Sapkota, S., Vergote, D., Westaway, D., Jhamandas, J., & Dixon, R. A. (2014). Synergistic associations of COMT and BDNF with executive function in aging are selective and modified by APOE. [Advance online publication.] Neurobiology of Aging. http://dx.doi.org/10.1016/j.neurobiolaging.2014.06.020
80. Saxby, B. K., Harrington, F., McKeith, I. G., Wesnes, K., & Ford, G. A. (2003). Effects of hypertension on attention, memory, and executive function in older adults. Health Psychology, 22, 587-591. http://dx.doi.org/10.1037/0278-6133.22.6.587
81. Schiepers, O. J. G., Harris, S. E., Gow, A. J., Pattie, A., Brett, C. E., Starr, J. M., & Deary, I. J. (2012). APOE E4 status predicts age-related cognitive decline in the ninth decade: Longitudinal follow-up of the Lothian Birth Cohort 1921. Molecular Psychiatry, 17, 315-324. http://dx.doi.org/10.1038/mp.2010.137
82. Schiffrin, E. L. (2004). Vascular stiffening and arterial compliance. Implications for systolic blood pressure. American Journal of Hypertension, 17, 39S-48S. http://dx.doi.org/10.1016/j.amjhyper.2004.08.019
83. Singer, J. D., & Willett, J. B. (2003). Applied longitudinal data analysis: Modeling change and event occurrence. New York, NY: Oxford University Press. http://dx.doi.org/10.1093/acprof:oso/9780195152968.001.0001
84. Small, B. J., Dixon, R. A., & McArdle, J. J. (2011). Tracking cognitionhealth changes from 55 to 95 years of age. The Journals of Gerontology Series B: Psychological Sciences and Social Sciences, 66 (Suppl. 1), i153-i161. http://dx.doi.org/10.1093/geronb/gbq093
85. Small, B. J., Rosnick, C. B., Fratiglioni, L., & Bäckman, L. (2004). Apolipoprotein E and cognitive performance: A meta-analysis. Psychology and Aging, 19, 592-600. http://dx.doi.org/10.1037/0882-7974.19.4.592
86. Smith, J. D. (2002). Apolipoproteins and aging: Emerging mechanisms. Ageing Research Reviews, 1, 345-365. http://dx.doi.org/10.1016/S1568-1637(02)00005-3
87. Song, X., Mitnitski, A., & Rockwood, K. (2011). Nontraditional risk factors combine to predict Alzheimer disease and dementia. Neurology, 77, 227-234. http://dx.doi.org/10.1212/WNL.0b013e318225c6bc
88. Sternäng, O., & Wahlin, Å. (2011). What is the role of apolipoprotein E for cognitive functioning across the lifespan? Biological Psychiatry, 70, 109-110.
89. Sternäng, O., Wahlin, Å., Adolfsson, R., Sleegers, K., Van Broeckhoven, C., & Nilsson L.-G. (2009). APOE and lipid level synergy effects on declarative memory functioning in adulthood. European Psychologist, 14, 268-278.
90. Sullivan, P. M., Han, B., Liu, F., Mace, B. E., Ervin, J. F., Wu, S., . . . Bales, K. R. (2011). Reduced levels of human apoE4 protein in an animal model of cognitive impairment. Neurobiology of Aging, 32, 791-801. http://dx.doi.org/10.1016/j.neurobiolaging.2009.05.011
91. Tulving, E. (1987). Multiple memory systems and consciousness. Human Neurobiology, 6, 67-80.
92. Vakil, E., & Blachstein, H. (1993). Rey Auditory-Verbal Learning Test: Structure analysis. Journal of Clinical Psychology, 49, 883-890. http://dx.doi.org/10.1002/1097-4679(199311)49:6_883::AIDJCLP22704906163.0.CO;2-6
93. Vandal, M., Alata, W., Tremblay, C., Rioux-Perreault, C., Salem, N., Jr., Calon, F., & Plourde, M. (2014). Reduction in DHA transport to the brain of mice expressing human APOE4 compared to APOE2. Journal of Neurochemistry, 129, 516-526. http://dx.doi.org/10.1111/jnc.12640
94. Verghese, P. B., Castellano, J. M., & Holtzman, D. M. (2011). Apolipoprotein E in Alzheimer's disease and other neurological disorders. Lancet Neurology, 10, 241-252. http://dx.doi.org/10.1016/S1474-4422(10)70325-2
95. Waldstein, S. R., Rice, S. C., Thayer, J. F., Najjar, S. S., Scuteri, A., & Zonderman, A. B. (2008). Pulse pressure and pulse wave velocity are related to cognitive decline in the Baltimore Longitudinal Study of Aging. Hypertension, 51, 99-104. http://dx.doi.org/10.1161/HYPERTENSIONAHA.107.093674
96. Waldstein, S. R., Wendell, C. R., Lefkowitz, D. M., Siegel, E. L., Rosenberger, W. F., Spencer, R. J., . . . Katzel, L. I. (2012). Interactive relations of blood pressure and age to subclinical cerebrovascular disease. Journal of Hypertension, 30, 2352-2356. http://dx.doi.org/10.1097/HJH.0b013e3283595651
97. Wilson, R. S., Bienias, J. L., Berry-Kravis, E., Evans, D. A., & Bennett, D. A. (2002). The apolipoprotein E epsilon 2 allele and decline in episodic memory. Journal of Neurology, Neurosurgery & Psychiatry, 73, 672-677. http://dx.doi.org/10.1136/jnnp.73.6.672
98. Wisdom, N. M., Callahan, J. L., & Hawkins, K. A. (2011). The effects of apolipoprotein E on non-impaired cognitive functioning: A metaanalysis. Neurobiology of Aging, 32, 63-74. http://dx.doi.org/10.1016/j.neurobiolaging.2009.02.003
99. Yasuno, F., Tanimukai, S., Sasaki, M., Ikejima, C., Yamashita, F., Kodama, C., . . . Asada, T. (2012). Effect of plasma lipids, hypertension and APOE genotype on cognitive decline. Neurobiology of Aging, 33, 2633-2640. http://dx.doi.org/10.1016/j.neurobiolaging.2011.12.028
100. Zade, D., Beiser, A., McGlinchey, R., Au, R., Seshadri, S., Palumbo, C., . . . Milberg, W. (2010). Interactive effects of apolipoprotein E type 4 genotype and cerebrovascular risk on neuropsychological performance and structural brain changes. Journal of Stroke and Cerebrovascular Diseases, 19, 261-268. http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2009.05.001
101. Zade, D., Beiser, A., McGlinchey, R., Au, R., Seshadri, S., Palumbo, C., . . . Milberg, W. (2013). Apolipoprotein epsilon 4 allele modifies waist-to-hip ratio effects on cognition and brain structure. Journal of Stroke and Cerebrovascular Diseases, 22, 119-125. http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2011.06.020
102. Zlokovic, B. V. (2011). Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nature Reviews Neuroscience, 12, 723-738.
103. Zlokovic, B. V. (2013). Cerebrovascular effects of apolipoprotein E: Implications for Alzheimer disease. Journal of the American Medical Association Neurology, 70, 440-444. http://dx.doi.org/10.1001/jamaneurol.2013.2152